Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine

Owing to the high heterogeneity of pancreatic cancer, patient-derived xenografts (PDX) can compensate for the defects of cell line-derived xenografts (CDX) and also better preserve the heterogeneity and tumor microenvironment of primary tumors. Further, gemcitabine, which is used for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, He, Wu, Pengpeng, Guo, Chenbo, Zhang, Caiqin, Zhao, Yong, Tan, Dengxu, An, Jiaze, Shi, Changhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166468/
https://www.ncbi.nlm.nih.gov/pubmed/35669987
http://dx.doi.org/10.1016/j.bbrep.2022.101291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166468/
https://www.ncbi.nlm.nih.gov/pubmed/35669987
http://dx.doi.org/10.1016/j.bbrep.2022.101291

Ejemplares similares